Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Operating Income (2016 - 2025)

Dexcom (DXCM) has disclosed Operating Income for 16 consecutive years, with $323.0 million as the latest value for Q4 2025.

  • Quarterly Operating Income rose 70.99% to $323.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $911.8 million through Dec 2025, up 51.97% year-over-year, with the annual reading at $911.8 million for FY2025, 51.97% up from the prior year.
  • Operating Income for Q4 2025 was $323.0 million at Dexcom, up from $242.5 million in the prior quarter.
  • The five-year high for Operating Income was $323.0 million in Q4 2025, with the low at $600000.0 in Q4 2021.
  • Average Operating Income over 5 years is $138.3 million, with a median of $130.9 million recorded in 2023.
  • The sharpest move saw Operating Income tumbled 99.42% in 2021, then soared 20800.0% in 2022.
  • Over 5 years, Operating Income stood at $600000.0 in 2021, then skyrocketed by 20800.0% to $125.4 million in 2022, then surged by 72.97% to $216.9 million in 2023, then dropped by 12.91% to $188.9 million in 2024, then soared by 70.99% to $323.0 million in 2025.
  • According to Business Quant data, Operating Income over the past three periods came in at $323.0 million, $242.5 million, and $212.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.